Gilead Sciences Inc (NAS:GILD)
$ 64.6 -0.34 (-0.52%) Market Cap: 80.48 Bil Enterprise Value: 98.68 Bil PE Ratio: 179.39 PB Ratio: 4.61 GF Score: 74/100

Gilead Sciences Inc to Acquire Forty Seven Inc - Conference Call Transcript

Mar 02, 2020 / 01:00PM GMT
Release Date Price: $75.4 (+8.71%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Gilead Sciences Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Douglas Maffei, Head of Investor Relations. Thank you. Please go ahead.

Douglas Maffei
Gilead Sciences, Inc. - Senior Director of IR

Thank you, Shannon. We appreciate everyone joining us on such short notice for today's call to discuss the exciting acquisition of Forty Seven announced earlier this morning.

The speakers on today's call will be Daniel O'Day, Chairman and Chief Executive Officer; Merdad Parsey, Chief Medical Officer; and Andy Dickinson, Chief Financial Officer. Also on the call is Johanna Mercier, Chief Commercial Officer.

Before we begin, let me remind you that we will be making forward-looking statements that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those referred to in any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot